Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Horizon Therapeutics Named one of the Best Places to Work in Chicago by Crain’s Chicago Business
01:00pm, Monday, 10'th Aug 2020
Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been named to the Crain’s Chicago Business 2020 Best Places to Work in Chicago list.
3 Monster Growth Stocks That Can Rip Higher
01:10pm, Sunday, 09'th Aug 2020
Out on Wall Street, where has focus landed? Squarely on growth. Specifically, investors want to know just how high stocks can climb. Plummeting to a low point in March, the market has bounced back inc
Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) Business Is Trailing The Market But Its Shares Aren't
02:58pm, Saturday, 08'th Aug 2020
Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) price-to-earnings (or "P/E") ratio of 27.8x might make it...
Horizon Therapeutics plc Announces Pricing of Public Offering of Ordinary Shares
03:20am, Friday, 07'th Aug 2020
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the pricing of its underwritten public offering of 11,800,000 of its ordinary shares at a price to the public of $71.00 per share. The net proce
Horizon Therapeutics Named 2020 Top Workplace for Millennials by Fortune
01:00pm, Thursday, 06'th Aug 2020
Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been named to the 2020 Fortune Best Workplaces for Millennials™ list. Horizon ranked 7th among 25 companies in the small and mediu
Horizon Therapeutics plc Announces Proposed Public Offering of Ordinary Shares
08:01pm, Wednesday, 05'th Aug 2020
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it is offering to sell $700,000,000 of its ordinary shares in an underwritten public offering. The Company also expects to grant the underw
Why Horizon Therapeutics Stock Is Up Today
04:26pm, Wednesday, 05'th Aug 2020
Shares of Horizon Therapeutics (NASDAQ: HZNP) are up by 17% as of 11:54 a.m. EDT on Wednesday, after the company reported better-than-expected second-quarter financial results before the market opened
Recap: Horizon Therapeutics Q2 Earnings
11:46am, Wednesday, 05'th Aug 2020
Shares of Horizon Therapeutics (NASDAQ:HZNP) were unchanged after the company reported Q2 results.Quarterly Results Earnings per share fell 18.37% over the past year to $0.40, which beat the estimate
Horizon Therapeutics Record Second-Quarter 2020 Results; Increased Guidance
Horizon announced topline data adding to the growing body of evidence supporting the efficacy and safety of TEPEZZA for Thyroid Eye Disease (TED).
Horizon Therapeutics' (NASDAQ:HZNP) Wonderful 383% Share Price Increase Shows How Capitalism Can Build Wealth
06:25pm, Friday, 24'th Jul 2020
We think that it's fair to say that the possibility of finding fantastic multi-year winners is what motivates many...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company has reached target patient enrollment for its Methotrexate to Increase Response Rates in Patients With Uncontrolled GOut Receiv
Horizon Therapeutics plc to Release Second-Quarter 2020 Financial Results and Host Webcast on Aug. 5, 2020
12:30pm, Monday, 13'th Jul 2020
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its second-quarter 2020 financial results will be released on Wednesday, Aug. 5, 2020. Following the announcement, Horizon's management wil
Centers for Medicare & Medicaid Services (CMS) Issues Permanent J-Code for TEPEZZA® (teprotumumab-trbw) Effective Oct. 1, 2020
12:30pm, Thursday, 09'th Jul 2020
Horizon Therapeutics announced that the U.S. Centers for Medicare and Medicaid Services has assigned a permanent J-code (J3241) for TEPEZZA.
HemoShear Therapeutics Achieves Milestone in Exclusive Drug Discovery Collaboration with Horizon Therapeutics in Gout
12:00pm, Thursday, 09'th Jul 2020
HemoShear Therapeutics, LLC, a privately held clinical stage biotechnology company, has achieved a research milestone in its collaboration with Horizon Therapeutics plc (Nasdaq: HZNP) to discover and
